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A novel ligand bearing a central piperidinyl sulfonamide group, N(SO2 pip)dpa, and its corresponding Re tricarbonyl complex,
[Re(CO)3 (N(SO2 pip)dpa)]+ , have been synthesized in good yield. The methylene CH2 signal seen as a singlet (4.54 ppm) in a 1 H
NMR spectrum of the ligand in DMSO-𝑑6 appears as two doublets (5.39, 5.01 ppm) in a spectrum of the [Re(CO)3 (N(SO2 pip)dpa)]+
complex and confirms the presence of magnetically nonequivalent protons upon coordination to Re. Structural results revealed that
the Re–N bond lengths fall within the normal range establishing coordination of ligand to metal. The presence of intraligand 𝜋 → 𝜋∗
and 𝑛 → 𝜋∗ transitions is indicated by the absorption peaks around 200–250 nm in UV-visible spectra. Absorption peaks in UVvisible spectra around 300 nm for metal complexes were identified as MLCT transitions. The S–N stretch observed as a strong peak
at 923 cm−1 for N(SO2 pip)dpa appeared at a shorter frequency, at 830 cm−1 in an FTIR spectrum of the [Re(CO)3 (N(SO2 pip)dpa)]+ .
The intense fluorescence displayed by the N(SO2 pip)dpa ligand has quenched upon coordination to Re. Relatively low IC50
values given by human breast cancer cells, MCF-7, (N(SO2 pip)dpa = 139 𝜇M, [Re(CO)3 (N(SO2 pip)dpa)]+ = 360 𝜇M) indicate that
N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+ are promising novel compounds that can be further investigated on their usage as
potential anticancer agents.

1. Introduction
Historically, fac-Re(CO)3 L complexes have provided a good
model system to interpret the nature of its analogous
99m
Tc agents which are widely used in imaging. The fac[Re(CO)3 (H2 O)3 ]+ precursor may be easily utilized [1] for the
synthesis of new organometallic complexes having suitable
pharmaceutical properties. Furthermore, the triaquatricarbonyl complex of 99m Tc, which is the group seven congener
of rhenium, is commercially available as a kit preparation [2],
enabling the easy simulation of the nonradioactive rhenium
complexes [3]. The use of nonradioactive rhenium facilitates
the synthesis of the metal complexes rather than handling
radioactive metal tracers.

Metal complexes (M = 99m Tc, Re) bearing symmetrical
linear tridentate ligands have been reported to possess lower
bioaccumulation than complexes bearing bidentate or monodentate ligands [2], resulting in fewer side effects when used
on the long term. Rhenium, in its lowest oxidation state,
is less sensitive to chemical attack by the reactive species
that may be present in cellular environment [2]. Facially
arranged carbonyl ligands cover one face of the distorted
octahedral complex thus protecting the metal center. Metal
carbon bonds are greatly stabilized by strong backdonation
from the carbonyl ligand to the metal. As rhenium is a soft
metal center, it prefers soft donors such as nitrogen and
tridentate metal complexes with nitrogen donors are widely
used [2, 4, 5].
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Scheme 1: Synthetic routes for the preparation of N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]BF4 .

Among various types of chronic human diseases, certain
types of cancers are widely treated by organometallic complexes [6, 7]. Breast cancer is one of the most abundant types
of cancer in recent times. However, only a few metallopharmaceuticals are available for diagnostic and therapeutic
purposes for human breast cancer [7, 8].
Sigma receptors are a distinct class of proteins that
are mostly found in the central nervous system [9]. Sigma
receptors are virtually absent in healthy human breast cells;
however, they appear in a high density in breast tumor
biopsy tissue [9, 10]. Proliferative human breast cancer cells
express approximately ten times more sigma receptors per
cell than the quiescent cells [9]. Therefore, high densities
of sigma receptors in rapidly proliferating breast cancer
cells make them ideal candidates for diagnosis as well as
therapy of breast cancer. Due to the multiple binding sites
containing lipophilic sterol binding domains on the protein
molecule, various types of exogenous ligands, such as several
derivatives of piperidine, piperazine [11, 12], benzamides
[13], and alkylamine [14], have been reported as potential
pharmaceuticals for therapy of human breast cancer, mainly
because these types of compounds preferentially bind with
sigma receptors [10].
To the best of our knowledge, there are only a few
radiotracers in which the piperidinyl group has been utilized towards targeting sigma receptors; Satpati et al. have
synthesized 99m Tc based cancer diagnostic agents [10], Choi
et al. have developed a 99m Tc labeled sigma-2 receptorspecific ligand as a potential breast tumor imaging agent [9],
and Caveliers et al. have utilized N-[2-(1 -piperidinyl)ethyl]3-123 I-iodo-4-methoxybenzamide [8]. Only the latter has
entered clinical trials for the diagnosis of patients with
primary breast cancer.
We based our study on the fact that fac[Re(CO)3 (N(R)dpa)]+ complexes have been reported to
possess promising biomedical properties where R equals
a suitable substituent linked by a N–C bond at the central
nitrogen in dipicolylamine [15]. Furthermore, the tertiary
sulfonamide linkage has recently been utilized to propose a
new approach to radiopharmaceutical bioconjugation [5].
We also envisage that the target specificity may be increased
by incorporating a piperidinyl derivative into the novel
compounds.

Our goal has been to synthesize a novel ligand and its
rhenium tricarbonyl complex having possible therapeutic
potential, with the long term goal of extending this study
to 99m Tc complexes towards the eventual diagnosis of breast
cancer. Thus, in this study we report the synthesis and characterization of a novel piperidinyl appended dipicolylamine
ligand and its corresponding Re tricarbonyl complex and
go one step further to report their potential applicability in
biological systems as anticancer agents (Scheme 1).

2. Experimental
2.1. Materials and Methods. Re2 (CO)10 , AgOTf, piperidine1-sulfonyl chloride, di(2-picolyl)amine, NaBF4 , anhydrous
sodium sulphate, acetone, methanol, dichloromethane, chromasolv water, and dioxane were obtained from Sigma
Aldrich, USA. Human breast cancer cell line MCF-7 was
obtained from American Type Culture Collection. All the
solvents and chemicals were of analytical grade and were used
as received, without further purification.
2.2. NMR Measurements. 1 H NMR spectra were recorded
in DMSO-𝑑6 on a Bruker 400 MHz spectrometer. Peak
positions are relative to trimethylsilane (TMS) as reference.
All NMR data were processed with TopSpin 3.2 and MestReC
software.
2.3. X-Ray Data Collection and Structure Determination.
Single crystals were placed in a cooled nitrogen gas
stream at 90 K on a Bruker Kappa Apex-II DUO diffractometer equipped with Cu K𝛼 (𝜆 = 1.54178 >) radiation
(N(SO2 pip)dpa ligand) or Mo K𝛼 radiation (𝜆 = 0.71073 Å)
([Re(CO)3 (N(SO2 pip)dpa)]BF4 complex). Refinement was
performed by full-matrix least squares methods using
SHELXL (Sheldrick (2008)) [16], with H atoms in idealized
positions. Molecular graphics are drawn using ORTEP-3 for
windows [17].
2.4. UV-Visible Spectroscopy. Electronic spectra for ligand
and metal complex were obtained on Spectro UV-VIS
autoversion 3.10, UV-2602 spectrophotometer. The spectral range was 190 nm–1100 nm. Spectra were obtained in

Bioinorganic Chemistry and Applications
methanol with base line correction. Spectral data were processed with UV WIN software.
2.5. FTIR Analysis. FTIR spectra were recorded on a Thermo
Scientific Nicolet iS10 spectrophotometer. ATR spectra were
obtained within the 4000–600 cm−1 spectral range. Spectral
data were processed with OMNIC software.
2.6. Fluorometric Analysis. Excitation and emission spectra
for ligand and metal complex were obtained in methanol and
acetonitrile on a Thermo Scientific Lumina spectrophotometer. A 150 W Xenon lamp was used as the excitation source.
Spectral data were processed with Luminous software.
2.7. Synthesis. In order to synthesize metal complexes,
[Re(CO)3 (H2 O)3 ]OTf precursor was prepared using
Re2 (CO)10 as the starting material according to a known
procedure [1].
2.7.1. N(SO2 pip)dpa Ligand. A solution of piperidine-1sulfonyl chloride (0.034 g, 5 mmol) in 25 mL of dioxane was
added dropwise over a period of 2 hours to a solution of
N(H)dpa (0.057 g, 10 mmol) in 100 mL of dioxane at 20∘ C.
The reaction mixture was stirred at room temperature for 24
hours and then filtered to remove any precipitate. Thereafter,
the dioxane was completely removed by rotary evaporation.
Slightly acidic water (30 mL, pH ∼ 5) was added to the
resulting compound, and the product was extracted into
CH2 Cl2 (2 × 25 mL). The CH2 Cl2 extracts were combined,
washed with water (2 × 25 mL), and taken to dryness. Grey
color, plate-like crystals were obtained. 1 H NMR signals
(ppm) in DMSO-𝑑6 are 8.49(d, 2H, H6/H6 ), 7.75(t, 2H,
H4/H4 ), 7.35(d, 2H, H3/H3 ), 7.27(t, 2H, H5/H5 ), 4.53(s,
2CH2 ), 3.09(s, 2H, Ha), and 1.40(s, 2H, Hb).
2.7.2. [Re(CO)3 (N(SO2 pip)dpa)]BF4 Complex. A solution
of N(SO2 pip)dpa (0.0346 g, 0.1 mmol) in 3 mL methanol
was treated with aqueous [Re(CO)3 (H2 O)3 ]OTf (0.1 mmol,
4 mL). Methanol (3 mL) was added to dissolve the precipitate
which formed. Acidity of the solution was measured (pH ∼
6) and the clear solution was heated at reflux for 16 h. A slight
excess of NaBF4 was added to the clear, brownish yellow color
solution. The solution was then allowed to develop crystals
over three days at room temperature after which block-like,
colorless crystals were obtained. 1 H NMR signals (ppm) in
DMSO-𝑑6 are 8.84(d, 2H, H6/H6 ), 8.06(t, 2H, H4/H4 ),
7.61(d, 2H, H3/H3 ), 7.47(t, 2H, H5/H5 ), 5.39(d, endo-H),
5.01(d, exo-H), 3.68(s, 2H, Ha), and 1.68(s, 2H, Hb).
2.8. Biological Assays
2.8.1. Cytotoxicity Assessment. The novel ligand and its metal
complex were investigated for their cytotoxicity against MCF7 (breast cancer) cells. Cells were cultured in 96-well culture plates and exposed to 25 𝜇g/mL, 50 𝜇g/mL, 100 𝜇g/mL,
200 𝜇g/mL, and 400 𝜇g/mL concentrations of ligand and
complex for 24 h, 48 h, and 72 h, respectively, and cytotoxicity
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was assessed by Sulforhodamine B assay [18]. All exposures
were carried out in triplicate. Briefly, the cell supernatant
was completely removed and washed with phosphate buffer
solution. Trichloroacetic acid (50%, 25 𝜇L) was added on
top of fetal bovine serum-free fresh medium (200 𝜇L) to
make final concentration of 10% trichloroacetic acid and
was incubated at 4∘ C for one hour former to the SRB assay.
The plate was then washed with five washing cycles with
water and dried completely. An aliquot of 100 𝜇L of 0.4%
Sulforhodamine B dissolved in 1% trichloroacetic acid, was
added to each well, and was allowed to stain for 15 minutes.
The plate was again washed with five washing cycles to
remove unbound dye using 1% (vol/vol) acetic acid after
removing the stain. The protein bound dye was solubilized
with trisbase (10 mM, pH 7.5, 200 𝜇L), after air-drying. The
plates were then shaken for 60 minutes to homogenize the
dye solution. The absorbance was then measured at 540 nm
using Synergy HTBioTek microplate reader. The percentage
viability was calculated by the equation given below:
Viable cell (%) =

Absorbance of treated cells
Absorbance of untreated cells

(1)

× 100.

3. Results and Discussion
3.1. Structural Results. Crystal data and details of
the structural refinement for N(SO2 pip)dpa and
[Re(CO)3 (N(SO2 pip)dpa)]+ are summarized in Table 1.
Crystallographic data are deposited with the Cambridge
Crystallographic Data Centre under deposition numbers
CCDC 1495607 and 1495608.
The uncoordinated ligand (Figure 1) possesses S–N(2)
bond length of 1.6194 (11) Å (Table 2). However, upon forming
the metal complex, the S–N(2) bond length has increased
(1.777 (2) Å). This may be attributed to the donation of
lone electron pair on sulfonamide nitrogen to Re, which
results in lowering of the strength of the S–N bond. Previous
studies have reported that the S–N distance is ∼1.73–1.76 Å
[5] when Re–N(sulfonamide) bond is strong [19]. The above
observation provides evidence that the complexation of the
ligand with Re has occurred successfully. Weakly coordinated
or noncoordinated sulfonamide groups have considerable
double character. This is because of the conjugation of lone
electron pair of the sulfonamide nitrogen with S=O across the
S–N bond [19].
In the N(SO2 pip)dpa ligand, planar geometry is observed
at N2 nitrogen which is sp2 hybridized. Therefore, C6, C7, and
S species are oriented in an angle of ∼120∘ to the central N2
(Table 3). All the other bond angles of the ligand lie within
the normal values depending on their hybridization.
In the [Re(CO)3 (N(SO2 pip)dpa)]+ complex, the coordination geometry at Re exhibits a pseudo octahedral structure
(Figure 1). This deviation may be due to the facial arrangement of tridentate chelating unit which leads to forming two
strained, five-membered rings at Re resulting in a N–Re–N
bond angle < 90∘ . The remaining three coordination sites of
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Table 1: Crystal data and structure refinement for N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+ .
Crystal data
Empirical formula

N(SO2 pip)dpa
C17 H22 N4 O2 S

[Re(CO)3 (N(SO2 pip)dpa)]+
C20 H22 N4 O5 ReS⋅BF4 0.682(CH3 OH)⋅0.318(H2 O)

Mr

346.44

731.03

Crystal system

Triclinic

Monoclinic

Space group
Unit cell dimensions
𝑎 (Å)
𝑏 (>)
𝑐 (>)
𝛼 (deg)
𝛽 (deg)
𝛾 (deg)
𝑉 (Å3 )
𝑇 (K)
Z
𝜌calc (g/cm3 )
abs coeff (mm−1 )
2𝜃max (deg)
𝑅[𝐹2 > 2𝜎(𝐹2 )]
𝑤𝑅(𝐹2)
Res density
Data/parameters
Radiation type
Radiation wavelength/(Å)

𝑃1

𝑃21 /𝑐

8.6557 (3)
10.1132 (3)
10.4022 (3)
71.979 (1)
81.262 (1)
74.382 (1)
831.59 (5)
90
2
1.384
1.88
135
0.030
0.086
0.29, −0.41
2819/217
Cu 𝐾𝛼
1.54178

10.8932 (4)
11.7517 (5)
20.7973 (8)
—
102.260 (2)
—
2601.62 (18)
90
4
1.866
4.82
66.2
0.027
0.058
1.50, −1.65
9917/354
Mo 𝐾𝛼
0.71073

C18

C17

C19
C16
C16

C20
N4

C17

C15

O2
N4

O1

C14

S

O5
C4

S1

C6
C5

C7

N2

C13
C9
C10
C5

C3

C8

C6

N1

C3
C2

C7

C11

N3

C10
C15
O3

Re

O1 C13

C12

C1

N1

C2

C9

C8
N2

C4

O4

C11

C14

C1

N3

C12
O2

(a)

(b)
+

Figure 1: ORTEP plot of N(SO2 pip)dpa (a) and the cation in [Re(CO)3 (N(SO2 pip)dpa)] (b). Thermal ellipsoids are drawn with 50%
probability.
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Table 2: Selected bond distances (Å) for N(SO2 pip)dpa.
S1–O1
S1–O2
S1–N2
S1–N4
N1–C5
N1–C1
N3–C8
N3–C12
N2–C7
N2–C6
N4–C13
N4–C17

Bond length (Å)
1.4363 (10)
1.4369 (10)
1.6194 (11)
1.6329 (11)
1.3391 (18)
1.3422 (18)
1.3373 (18)
1.3459 (18)
1.4657 (16)
1.4615 (16)
1.4848 (16)
1.4838 (17)

Table 3: Selected bond angles (deg) for N(SO2 pip)dpa.
O1–S1–O2
O1–S1–N2
O2–S1–N2
O1–S1–N4
O2–S1–N4
N2–S1–N4
N2–C6–C5
N1–C5–C4
N1–C5–C6
C4–C5–C6
C5–N1–C1
C8–N3–C12
C6–N2–C7
C6–N2–S1
C7–N2–S1
C17–N4–C13

Bond angle (deg)
116.88 (6)
106.19 (6)
111.30 (6)
113.83 (6)
106.15 (6)
101.48 (5)
113.65 (10)
122.65 (12)
116.86 (11)
120.47 (12)
117.42 (11)
117.28 (11)
118.01 (10)
118.33 (9)
122.54 (9)
113.03 (10)

the opposite face of the octahedron are occupied by three
carbonyl ligands.
The distance of new bonds formed between Re and nitrogen atoms in dipicolylamine lies within the range of normal
values. Generally, the distance between Re and sp2 hybridized
nitrogen in a Re complex with prototypical NNN donor
ligand is 2.14–2.18 Å [4, 20]. The coordination bond between
Re and sp2 hybridized nitrogen in the pyridyl rings which
are denoted as N1 and N3 (Figure 1) exhibits a bond distance
close to that of the prototypical bond (Table 4). Similarly, the
coordination bond between Re and sp3 hybridized tertiary
nitrogen (2.251 (2) Å), though exceeding the normal range
(2.23–2.29 Å) [4, 20], is less than the Re–N2 distance of 2.2826
(16) Å of [Re(CO)3 (N(SO2 Me)dpa]PF6 [5] and confirms
rehybridization of sulfonamide nitrogen from sp2 to sp3 when
bound to Re. Further evidence for the rehybridization of
sulfonamide nitrogen from sp2 to sp3 upon binding to Re
is provided by the fact that the bond angles of this tertiary
sulfonamide nitrogen are closer to 109.5∘ (Table 5). All the

Table
4:
Selected
[Re(CO)3 (N(SO2 pip)dpa)]+ .

bond

distances

N1–Re–N3
N1–Re–N2
N3–Re–N2
C13–Re–C15
C13–Re–N1
N2–Re–C15
N2–Re–C14
N2–Re–C13
C14–Re–N3
C15–Re–N3
C6–N2–Re
C7–N2–Re
S–N2–Re
N1–Re–C15
N1–Re–C14

for

Bond length (>)
2.1746 (19)
2.251 (2)
2.179 (2)
1.919 (3)
1.904 (3)
1.934 (2)
1.425 (2)
1.422 (2)
1.777 (2)
1.588 (2)

Re–N1
Re–N2
Re–N3
Re–C13
Re–C14
Re–C15
S–O4
S–O5
S–N2
S–N4
Table
5:
Selected
[Re(CO)3 (N(SO2 pip)dpa)]+ .

(>)

bond

angles

(deg)

for

Bond angle (deg)
77.55 (7)
77.98 (8)
76.58 (8)
88.25 (10)
98.09 (9)
97.00 (9)
171.70 (9)
98.43 (9)
96.37 (10)
95.81 (9)
108.74 (14)
107.06 (15)
113.31 (9)
172.39 (9)
96.36 (9)

other bond angles lie within the normal range of reported
compounds [5].
1
3.2.
H
NMR
Analysis. N(SO2 pip)dpa
and
[Re(CO)3 (N(SO2 pip)dpa)]+ were characterized using
1
H NMR spectroscopy in DMSO-𝑑6 . Peaks related to
residual solvents were also identified [21, 22]. Signals related
to the dipicolylamine were assigned according to previously
reported data of related compounds [5, 23]. Protons attached
to the pyridyl nitrogen (H6/6 ) are more deshielded and
thereby signals are located downfield in the spectrum
(Figure 2). Protons in the piperidinyl ring were assigned
with the aid of reported spectra of related compounds
[10]. The signal for protons in the methylene groups of the
N(SO2 pip)dpa appears as a singlet at (4.53 ppm) because
the protons attached to the two methylene groups are
magnetically equivalent due to free rotation. Singlet peaks
at 3.3, 2.5, 5.8, and 3.5 ppm are due to residual solvents
including water, DMSO, dichloromethane, and dioxane,
respectively [21, 22].
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–CH2
H6/6 H4/4 H3/3 H5/5

Exo-CH
Endo-CH
∗

9.0

8.0

7.0

6.0

5.0

4.0

(ppm)

Figure 2: 1 H NMR spectra in DMSO-𝑑6 of N(SO2 pip)dpa (lower) and [Re(CO)3 (N(SO2 pip)dpa)]+ (upper). ∗ Peak due to trace amounts of
CH2 Cl2 solvent.

Absorbance

1.2
1
0.8
0.6
0.4
0.2
0
200

250

300
Wavelength (nm)

350

400

Absorbance of [Re(CO)3 (N(SO2 pip)dpa]+
Absorbance of N(SO2 pip)dpa

Figure 3: UV-visible spectra of N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+ .

According to the spatial arrangement of the atoms in
[Re(CO)3 (N(SO2 pip)dpa)]+ , the methylene protons are projected towards and away from the carbonyl ligands attached
to rhenium and may be designated as endo-H and exo-H,
respectively. Therefore, those methylene protons are not magnetically equivalent. Hence, the singlet at 4.53 ppm related
to the CH2 group of the free ligand appears as two doublets
further downfield upon binding to the metal (Figure 2). All
the signals related to protons attached to pyridyl nitrogen
have shifted downfield upon binding to the metal (Table 6).
These shifts of peaks may be attributed to the electron
withdrawing inductive effect as a result of the formation
of direct Re–N bond and provide strong evidence of the
formation of the metal complex.
3.3. UV-Visible Analysis. The absorption peak at 307 nm
in [Re(CO)3 (N(SO2 pip)dpa)]+ may be attributed to MLCT
transition (Figure 3). Rhenium tricarbonyl complexes with
suitable ligands display MLCT transitions [24]. Other high
energy absorption peaks may be due to intraligand 𝜋 → 𝜋∗
and 𝑛 → 𝜋∗ transitions [24, 25].

aliphatic systems [26]. A narrow and sharp absorption band
at 2942 cm−1 is attributed to the C–H asymmetric stretching
vibration of aliphatic systems [26]. A strong absorption band
at 1136 cm−1 may be due to the symmetric stretching vibration
of S=O bond of the sulfonamide group [26]. A collection
of absorption peaks in the range between 1294 cm−1 and
1590 cm−1 is due to the symmetric and asymmetric stretching
vibrations of C=C bonds [26] in aromatic rings and C=N
stretching vibration mode in the ligand [26]. Stretching vibration due to S–N bond is identified as the strong absorption
peak at 923 cm−1 [27].
Most of the peaks attributed to ligand also appear in a
spectrum of the [Re(CO)3 (N(SO2 pip)dpa)]+ complex and,
in addition, two strong and intense absorption peaks at
2035 cm−1 and 1916 cm−1 are attributed to the stretching
vibrations of CO ligands in the Re(CO)3 core [28]. C–N
stretching vibrations in the pyridyl rings have shifted towards
lower frequencies. S–N stretching vibration has shifted to a
lower frequency (836 cm−1 ) due to lowering of initial bond
energy resulting from the sigma donation of lone electron
pairs on sp3 hybridized orbital in sulfonamide nitrogen.

3.4. FTIR Analysis. Literature has greatly aided in assigning
FTIR spectra of novel ligand and complex. In an FTIR
spectrum of N(SO2 pip)dpa, a short absorption band appears
at 3077 cm−1 due to the asymmetric stretching vibration of

3.5. Fluorometric Analysis. Fluorescence spectra were
obtained for N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+
in methanol and acetonitrile. The concentrations of the test
samples were approximately 0.01 mol/dm3 . 3D scans were
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Table 6: Comparison of the 1 H NMR shifts of N(SO2 pip)dpa ligand and [Re(CO)3 (N(SO2 pip)dpa)]+ complex in DMSO-𝑑6 .
H6/6
8.49 (d)
8.84 (d)

N(SO2 pip)dpa
[Re(CO)3 (N(SO2 pip)dpa)]+

H5/5
7.27 (t)
7.47 (t)

H4/4
7.75 (t)
8.06 (t)

H3/3
7.35 (d)
7.61 (d)

−CH2
4.53 (s)
5.39 (d), 5.01 (d)

Table 7: Excitation and emission wave lengths of N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+ in methanol and acetonitrile.
Test sample

Solvent
Methanol
Acetonitrile
Methanol
Acetonitrile

N(SO2 pip)dpa
[Re(CO)3 (N(SO2 pip)dpa)]+

Excitation wave length/nm
320
325
320
325

40000

Emission wave length/nm
468
475
430
435

Table 8: IC50 values reported for ligand and the complex at 24, 48,
and 72 hr incubation period.

Intensity

30000

Test compound
20000

Ligand
Complex

10000
0
300

350

400

500
550
450
Wavelength (nm)

650

700

N(SO2 pip)dpa

and

600

[Re(CO)3 (N(SO2 pip)dpa)]+
N(SO2 pip)dpa

Figure 4: Fluorescence spectra of
[Re(CO)3 (N(SO2 pip)dpa)]+ in acetonitrile.

done for the analysis and the relevant excitation and emission
details are summarized in Table 7.
N(SO2 pip)dpa displays high fluorescence emission in
methanol and the intensity was enhanced even more in
acetonitrile (Figure 4). These emissions may occur due to
the intraligand 𝜋 → 𝜋∗ and 𝑛 → 𝜋∗ transitions. However,
fluorescence intensity of [Re(CO)3 (N(SO2 pip)dpa)]+ has
lowered possibly due to the quenching of fluorescence upon
direct binding of sulfonamide nitrogen to the metal. Nevertheless, weak fluorescence of [Re(CO)3 (N(SO2 pip)dpa)]+
may arise due to the MLCT transition.
3.6. Antiproliferative Activity. Cytotoxicity in human breast
cancer cells (MCF-7) was induced upon addition of ligand
and complex at IC50 of 139 𝜇M and 360 𝜇M, respectively,
after 24 hr (Figure 5). This shows that, comparatively, human
breast cancer cells show higher sensitivity to the ligand
than its metal complex. These findings emphasize that
N(SO2 pip)dpa and [Re(CO)3 (N(SO2 pip)dpa)]+ are promising novel compounds that can be further investigated on their
usage as anticancer agents and cancer cell imaging agents.
Comparisons of the IC50 values obtained for ligand
and the complex at 24, 48, and 72 hr have shown that the
minimum test compound concentration needed to affect cell
viability increased with increasing incubation time (Table 8)

24 hr
262
283

IC50 values/𝜇M
48 hr
209
391

72 hr
95
915

for the complex whereas it has decreased with that of the
ligand. This emphasizes that, comparatively, ligand cytotoxicity is much higher than the metal complex toxicity.
Decreasing cytotoxicity may be an indicator of activation of
repair mechanisms after the initial cellular damage.
Morphology of human breast cancer cells upon treating
with test compounds at 24, 48, and 72 hr time periods was
micrographed and images were obtained as in Figures 6 and
7.
Morphology of the cells does not show significant change
under light microscopy indicative of antiproliferative activity.
However, the cell numbers in wells have an apparent change.
Beside cytotoxic effects, the ligand shows an acute effect by
48 hours but numbers seem to be increasing by 72 hours.
Cells may have resorted to a repair mechanism against the
cytotoxic effect of the ligand. However, when complexed with
Re, the decline of cell population seems to be continuing
beyond 72 hr, which shows a persistent effect and continued
antiproliferative activity.

4. Conclusions
A novel ligand and its corresponding rhenium complex
were synthesized in good yield and purity and characterized using single crystal X-ray diffraction, NMR, UVvisible, and FTIR spectroscopy. The near-normal Re–N
bond lengths as well as the relatively long N–S bond
demonstrate that tertiary sulfonamide serves as a good
donor in the [Re(CO)3 (N(SO2 pip)dpa)]+ complex. The
sp2 to sp3 rehybridization of sulfonamide nitrogen has
facilitated the binding of tertiary sulfonamide nitrogen
in the [Re(CO)3 (N(SO2 pip)dpa)]+ complex. The fluorescence of the free N(SO2 pip)dpa ligand was quenched
upon direct binding of the sulfonamide nitrogen to Re
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Percentage cell viability

100
80
60
40
20
0
0

200
400
Concentration (𝜇M)

600

Cell viability with complex (%)
Cell viability with ligand (%)

Figure 5: The plot of percentage cell viability versus concentration of the test compounds (𝜇M) obtained by Sulforhodamine B assay.
0 𝜇g/mL

25 𝜇g/mL

50 𝜇g/mL

100 𝜇g/mL

200 𝜇g/mL

400 𝜇g/mL

24 hr
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72 hr

Figure 6: Morphology of human breast cancer cells (MCF-7), after 24, 48, and 72 hr incubating with the N(SO2 pip)dpa ligand at increasing
concentrations.

in the metal complex resulting in weak fluorescence for
[Re(CO)3 (N(SO2 pip)dpa)]+ .
and
Cytotoxicity
for
both
N(SO2 pip)dpa
[Re(CO)3 (N(SO2 pip)dpa)]+ was determined against human
breast cancer cells (MCF-7) by Sulforhodamine B assay.
Effects of complex on breast cancer cells seem to decrease

with time but the ligand continues to exert the cytotoxic effect
where both compounds show promising antiproliferative
activity.
In conclusion, utilizing the conjugation approach
described by Perera and coworkers [5], we demonstrate
that a piperidinyl group may be successfully introduced

Bioinorganic Chemistry and Applications
0 𝜇g/mL

25 𝜇g/mL

9
50 𝜇g/mL

100 𝜇g/mL

200 𝜇g/mL

400 𝜇g/mL

24 hr

48 hr

72 hr

Figure 7: Morphology of human breast cancer cells (MCF-7), after 24, 48, and 72 hr incubating with the [Re(CO)3 (N(SO2 pip)dpa)]+ complex
at increasing concentrations.

to develop therapeutic and diagnostic agents because we
envisage that the synthesis reported here for nonradioactive
rhenium complexes may be extended to the 99m Tc core.

[2] R. Schibli and A. P. Schubiger, “Current use and future potential
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